FDA Inspection 1012564 — Louisville APL Diagnostics, Inc.

Louisville APL Diagnostics, Inc. — FEI 1000305932

The FDA completed an inspection of Louisville APL Diagnostics, Inc. on June 2, 2017 in Texas City, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 2, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Texas City, TX (United States)

Citations

IDCFRDescription
337521 CFR 820.198(e)Records of complaint investigation
53921 CFR 820.70(b)Production and Process Change Procedures, lack of or Inad.